ARCHIVES

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

November 9, 2007

ACS Offers New Grants to Physicians

September 7, 1984

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

Three Bomb Threats At NIH In One Week result In Evacuations, Investigations

August 2, 1996

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

Continuing Resolution Funds Agencies Through Dec. 5.

November 17, 2000